Published in J Manag Care Pharm on September 01, 2006
Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care (2009) 1.97
The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: a retrospective cross-sectional study using a national pharmacy claims database. BMC Health Serv Res (2013) 0.92
Egg consumption and risk of type 2 diabetes in older adults. Am J Clin Nutr (2010) 0.90
Trends of hospitalizations, fatality rate and costs for acute myocardial infarction among Spanish diabetic adults, 2001-2006. BMC Health Serv Res (2010) 0.83
Impact of inpatient diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge. Diabetes Res Clin Pract (2012) 0.81
Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes. Am Health Drug Benefits (2013) 0.81
Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples. PLoS One (2016) 0.81
Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitus. J Card Fail (2010) 0.80
Economic burden of hepatitis B infection among patients with diabetes. Hum Vaccin Immunother (2016) 0.75
Resource use associated with type 2 diabetes in Africa, the Middle East, South Asia, Eurasia and Turkey: results from the International Diabetes Management Practice Study (IDMPS). BMJ Open Diabetes Res Care (2017) 0.75
Patient-reported outcomes: instrument development and selection issues. Value Health (2007) 1.46
Promoting healthy eating and physical activity short-term effects of a mass media campaign. Am J Prev Med (2007) 1.45
Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers. J Aerosol Med (2004) 0.89
Analysis of safety from a human clinical trial with pterostilbene. J Toxicol (2013) 0.89
Development and validation of an onset of effect questionnaire for patients with asthma. Allergy Asthma Proc (2008) 0.77